作者
- Antman, E.M. (23)
- Braunwald, E. (33)
- Cannon, C.P. (106)
- Gibson, C. (9)
- Gibson, C.M. (15)
- Giugliano, R.P. (12)
- McCabe, C.H. (25)
- Morrow, D.A. (11)
- Murphy, S.A. (23)
- Sabatine, M.S. (14)
|
總筆數:106
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Relation between systemic anticoagulation as determined by activatedpartial thromboplastin time and heparin measurements and in-hospitalclinical events in unstable angina and non-Q wave myocardial infarction |
Becker, R.C.;Cannon, C.P.;Tracy, R.P.;Thompson, B.;Bovill, E.G.;Desvigne-Nickens, P.;Randall, A.M.Y.;Knatternud, G.;Braunwald, E.;Thrombolysis in Myocardial Ischemia III B Investigators; |
American Heart Journal |
1996-03-01 |
查看 |
| Relation between injections before 90-minute angiography and coronarypatency: Results of the Thrombolysis in Myocardial Infarction 4 Trial* |
Gibson, C.;Marble, S.J.;Rizzo, M.J.;Moynihan, J.;McLean, C.;Ryan, K.;Sparano, A.;Piana, R.N.;McCabe, C.;Cannon, C.P.; |
American Heart Journal |
1997-09-01 |
查看 |
| Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A |
Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
1997-10-01 |
查看 |
| Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A |
Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
1997-10-01 |
查看 |
| Relation of coagulation parameters to patency and recurrent ischemia inthe Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial |
For the TIMI II investigators;Tracy, R.P.;Kleiman, N.S.;Thompson, B.;Cannon, C.P.;Bovill, E.G.;Brown, R.;Collen, D.;Mahan, E.;Mann, K.G.;Rogers, W.J.;Sopko, G.;Stump, D.C.;Williams, D.O.;Zaret, B.L.; |
American Heart Journal |
1998-01-01 |
查看 |
| Relation of coagulation parameters to patency and recurrent ischemia inthe Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial |
For the TIMI II investigators;Tracy, R.P.;Kleiman, N.S.;Thompson, B.;Cannon, C.P.;Bovill, E.G.;Brown, R.;Collen, D.;Mahan, E.;Mann, K.G.;Rogers, W.J.;Sopko, G.;Stump, D.C.;Williams, D.O.;Zaret, B.L.; |
American Heart Journal |
1998-01-01 |
查看 |
| Timely thrombolysis: Synergism to open arteries and reduce mortalityrates |
Cannon, C.P.; |
American Heart Journal |
1999-01-01 |
查看 |
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Timely thrombolysis: Synergism to open arteries and reduce mortalityrates |
Cannon, C.P.; |
American Heart Journal |
1999-01-01 |
查看 |
| Timely thrombolysis: Synergism to open arteries and reduce mortalityrates |
Cannon, C.P.; |
American Heart Journal |
1999-01-01 |
查看 |
| Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience |
For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; |
American Heart Journal |
1999-01-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results |
For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results |
For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Racial differences in the management of unstable angina: Results fromthe multicenter GUARANTEE registry |
GUARANTEE Investigators;Scirica, B.M.;Moliterno, D.J.;Every, N.R.;Anderson, H.;Aguirre, F.V.;Granger, C.B.;Lambrew, C.T.;Rabbani, L.E.;Sapp, S.K.;Booth, J.E.;Ferguson, J.J.;Cannon, C.P.; |
American Heart Journal |
1999-12-01 |
查看 |
| Racial differences in the management of unstable angina: Results fromthe multicenter GUARANTEE registry |
GUARANTEE Investigators;Scirica, B.M.;Moliterno, D.J.;Every, N.R.;Anderson, H.;Aguirre, F.V.;Granger, C.B.;Lambrew, C.T.;Rabbani, L.E.;Sapp, S.K.;Booth, J.E.;Ferguson, J.J.;Cannon, C.P.; |
American Heart Journal |
1999-12-01 |
查看 |
| Multimodality reperfusion therapy for acute myocardial infarction |
Cannon, C.P.; |
American Heart Journal |
2000-11-01 |
查看 |
| Multimodality reperfusion therapy for acute myocardial infarction |
Cannon, C.P.; |
American Heart Journal |
2000-11-01 |
查看 |
| Exploring the issues of appropriate dosing in the treatment of acutemyocardial infarction: Potential benefits of bolus fibrinolytic agents |
Cannon, C.P.; |
American Heart Journal |
2000-12-01 |
查看 |
| Exploring the issues of appropriate dosing in the treatment of acutemyocardial infarction: Potential benefits of bolus fibrinolytic agents |
Cannon, C.P.; |
American Heart Journal |
2000-12-01 |
查看 |
| Exploring the issues of appropriate dosing in the treatment of acutemyocardial infarction: Potential benefits of bolus fibrinolytic agents |
Cannon, C.P.; |
American Heart Journal |
2000-12-01 |
查看 |
| Exploring the issues of appropriate dosing in the treatment of acutemyocardial infarction: Potential benefits of bolus fibrinolytic agents |
Cannon, C.P.; |
American Heart Journal |
2000-12-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogen activator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.M.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; |
American Heart Journal |
2001-05-01 |
查看 |
| Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy |
Srinivas, V.S.;Cannon, C.P.;Gibson, C.M.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; |
American Heart Journal |
2001-07-01 |
查看 |
| Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy |
Srinivas, V.S.;Cannon, C.P.;Gibson, C.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; |
American Heart Journal |
2001-07-01 |
查看 |
| To cath or not to cath? That used to be the question |
Cannon, C.P.; |
American Heart Journal |
2002-03-01 |
查看 |
| To cath or not to cath? That used to be the question |
Cannon, C.P.; |
American Heart Journal |
2002-03-01 |
查看 |
| To cath or not to cath? That used to be the question |
Cannon, C.P.; |
American Heart Journal |
2002-03-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.M.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Direct comparison of characteristics, treatment, and outcomes of patientsenrolled versus patients not enrolled in a clinical trial at centersparticipating in the TIMI 9 Trial and TIMI 9 Registry |
Bahit, M.C.;Cannon, C.P.;Antman, E.M.;Murphy, S.A.;Gibson, C.M.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2003-01-01 |
查看 |
| Prior peripheral arterial disease and cerebrovascular disease areindependent predictors of adverse outcome in patients with acute coronarysyndromes: Are we doing enough? Results from the Orbofiban in Patients withUnstable Coronary Syndromes-Thrombolysis In Myocardial Infarction(OPUS-TIMI) 16 study |
Cotter, G.;Cannon, C.P.;McCabe, C.H.;Michowitz, Y.;Kaluski, E.;Charlesworth, A.;Milo, O.;Bentley, J.;Blatt, A.;Krakover, R.;Zimlichman, R.;Reisin, L.;Marmor, A.;Lewis, B.;Vered, Z.;Caspi, A.;Braunwald, E.;OPUS-TIMI 16 Investigators; |
American Heart Journal |
2003-04-01 |
查看 |
| Optimizing glycoprotein IIb/IIIa receptor antagonist use for thenon-ST-segment elevation acute coronary syndromes: risk stratification andtherapeutic intervention |
Januzzi, J.L.;Cannon, C.P.;Theroux, P.;Boden, W.E.; |
American Heart Journal |
2003-11-01 |
查看 |
| Global patterns of use of antithrombotic and antiplatelet therapies inpatients with acute coronary syndromes: insights from the Global Registryof Acute Coronary Events (GRACE) |
Budaj, A.;Brieger, D.;Steg, P.G.;Goodman, S.G.;Dabbous, O.H.;Fox, K.A.A.;Avezum, A.;Cannon, C.P.;Mazurek, T.;Flather, M.D.;Van De Werf, F.;GRACE Investigators; |
American Heart Journal |
2003-12-01 |
查看 |
| Antibiotics for secondary prevention of coronary artery disease: an ACEShypothesis but we need to PROVE IT |
Gelfand, E.V.;Cannon, C.P.; |
American Heart Journal |
2004-02-01 |
查看 |
| Antibiotics for secondary prevention of coronary artery disease: an ACEShypothesis but we need to PROVE IT |
Gelfand, E.V.;Cannon, C.P.; |
American Heart Journal |
2004-02-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Early cardiac catheterization is associated with lower mortality only amonghigh-risk patients with ST- and non-ST-elevation acute coronary syndromes:Observations from the OPUS-TIMI 16 trial |
Cantor, W.J.;Goodman, S.G.;Cannon, C.P.;Murphy, S.A.;Charlesworth, A.;Braunwauld, E.;Langer, A.; |
American Heart Journal |
2005-02-01 |
查看 |
| Design and rationale of Clopidogrel as Adjunctive ReperfusionTherapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial |
Sabatine, M.S.;McCabe, C.H.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2005-02-01 |
查看 |
| Early cardiac catheterization is associated with lower mortality only amonghigh-risk patients with ST- and non-ST-elevation acute coronary syndromes:Observations from the OPUS-TIMI 16 trial |
Cantor, W.J.;Goodman, S.G.;Cannon, C.P.;Murphy, S.A.;Charlesworth, A.;Braunwauld, E.;Langer, A.; |
American Heart Journal |
2005-02-01 |
查看 |
|
|
|
